Acute phase proteins and IP-10 as triage tests for the diagnosis of tuberculosis: systematic review and meta-analysis. (February 2019)

• Record Type: Journal Article
• Authors: Santos, V.S.; Goletti, D.; Kontogianni, K.; Adams, E.R.; Molina-Moya, B.; Dominguez, J.; Crudu, V.; Martins-Filho, P.R.S.; Ruhwald, M.; Lawson, L.; Bimba, J.S.; Garcia-Basteiro, A.L.; Petrone, L.; Kabeer, B.S.; Reither, K.; Cuevas, L.E.
• Is Part Of: Clinical microbiology and infection. Volume 25:Number 2(2019)
• Page Start: 169
• Page End: 177
• Publication Date: 2019-02
• Subjects: Acute phase proteins -- IP-10 -- screening -- systematic review -- tuberculosis; Medical microbiology -- Periodicals; Diagnostic microbiology -- Periodicals; Communicable diseases -- Periodicals; Infection -- Periodicals; 616.01
• DOI: 10.1016/j.cmi.2018.07.017
• Languages: English
• ISSNs: 1198-743X

Abstract

Abstract: Objectives: We examined the data reported in studies for diagnostic purposes and to discuss whether their intended use could be extended to triage, as rule-in or rule-out tests to select individuals who should undergo further confirmatory tests. Methods: We searched Scopus, PubMed and Web of Science with the terms 'acute phase proteins, ' 'IP-10, ' 'tuberculosis, ' 'screening' and 'diagnosis, ' extracted the sensitivity and specificity of the biomarkers and explored methodologic differences to explain performance variations. Summary estimates were calculated using random-effects models for overall pooled accuracy. The hierarchical summary receiver operating characteristic model was used for meta-analysis. Results: We identified 14, four and one studies for C-reactive protein (CRP), interferon γ–induced protein 10 (IP-10) and alpha-1-acid glycoprotein (AGP). The pooled CRP sensitivity/specificity (95% confidence interval) was 89% (80–96) and 57% (36–65). Sensitivity/specificity were higher in high-tuberculosis-burden countries (90%/64%), HIV-infected individuals (91%/61%) and community-based studies (90%/62%). IP-10 sensitivity/specificity in TB vs. non-TB studies was 85%/63% and in TB and HIV coinfected vs. other lung conditions 94%/21%. However, IP-10 studies included diverse populations and a high risk of bias, resulting in very low-quality evidence. AGP had 86%/93% sensitivity/specificity. Conclusions: Few studies have evaluated CRP, IP-10 and AGP for the triage of symptomatic patients. Their high sensitivity and moderate specificity warrant further prospective studies exploring whether their combined use could optimize performance.